Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A Capital Reinvestment Ratio
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A capital reinvestment ratio. Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) has a Capital Reinvestment Ratio of 0.18x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥837.18 Million) in capital expenditures (CN¥152.89 Million). Check total reinvestment intensity of Anhui Huaren Health Pharmaceutical Co. L to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (2021–2025)
Capital reinvestment ratio of Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A from 2021 to 2025. This chart tracks Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A's Capital Reinvestment Ratio across 5 annual periods. Also explore Anhui Huaren Health Pharmaceutical Co. L annual equity growth to track the company's year-over-year net asset growth rate.
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A Capital Reinvestment Ratio by Year (2021–2025)
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A capital reinvestment ratio by year from 2021 to 2025. For the full cash flow conversion analysis, see 301408 operating cash flow.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.18x | CN¥837.18 Million | CN¥152.89 Million | ▼ -35.1% |
| 2024 | 0.28x | CN¥571.76 Million | CN¥160.89 Million | ▼ -82.9% |
| 2023 | 1.65x | CN¥131.37 Million | CN¥216.31 Million | ▲ +173.2% |
| 2022 | 0.60x | CN¥173.84 Million | CN¥104.77 Million | ▲ +150.3% |
| 2021 | 0.24x | CN¥140.82 Million | CN¥33.91 Million | — |